2017 Q4 Form 10-K Financial Statement
#000156459018006338 Filed on March 20, 2018
Income Statement
| Concept | 2017 Q4 | 2017 | 2016 Q4 |
|---|---|---|---|
| Revenue | $1.430M | $4.026M | $540.0K |
| YoY Change | 164.81% | 26.29% | -60.0% |
| Cost Of Revenue | $20.00K | $283.0K | $650.0K |
| YoY Change | -96.92% | -68.38% | -2.99% |
| Gross Profit | $1.410M | $3.743M | -$110.0K |
| YoY Change | -1381.82% | 63.24% | -116.18% |
| Gross Profit Margin | 98.6% | 92.97% | -20.37% |
| Selling, General & Admin | $2.240M | $10.65M | $3.370M |
| YoY Change | -33.53% | -13.05% | 17.01% |
| % of Gross Profit | 158.87% | 284.56% | |
| Research & Development | $2.170M | $7.407M | $1.990M |
| YoY Change | 9.05% | -14.5% | 6.42% |
| % of Gross Profit | 153.9% | 197.89% | |
| Depreciation & Amortization | $60.00K | $279.0K | $70.00K |
| YoY Change | -14.29% | -7.0% | -12.5% |
| % of Gross Profit | 4.26% | 7.45% | |
| Operating Expenses | $4.410M | $18.34M | $5.360M |
| YoY Change | -17.72% | -15.9% | 12.84% |
| Operating Profit | -$3.000M | -$14.32M | -$5.470M |
| YoY Change | -45.16% | -23.12% | 34.4% |
| Interest Expense | $0.00 | $747.0K | -$330.0K |
| YoY Change | -100.0% | -43.37% | -49.23% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $40.00K | $281.0K | $100.0K |
| YoY Change | -60.0% | -17.35% | -88.89% |
| Pretax Income | -$2.970M | -$15.68M | -$5.710M |
| YoY Change | -47.99% | -19.99% | 40.99% |
| Income Tax | -$10.00K | $26.00K | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$2.960M | -$15.71M | -$5.710M |
| YoY Change | -48.16% | -19.96% | 47.93% |
| Net Earnings / Revenue | -206.99% | -390.14% | -1057.41% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$1.390M | -$7.273M | -$2.572M |
| COMMON SHARES | |||
| Basic Shares Outstanding | |||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2017 Q4 | 2017 | 2016 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $13.02M | $13.02M | $50.56M |
| YoY Change | -74.25% | -74.25% | 0.64% |
| Cash & Equivalents | $9.125M | $9.130M | $2.013M |
| Short-Term Investments | $3.900M | $3.900M | $48.55M |
| Other Short-Term Assets | $560.0K | $560.0K | $880.0K |
| YoY Change | -36.36% | -36.36% | 27.54% |
| Inventory | $229.0K | $230.0K | $250.0K |
| Prepaid Expenses | |||
| Receivables | $1.231M | $1.240M | $530.0K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $15.05M | $15.05M | $52.22M |
| YoY Change | -71.19% | -71.18% | 0.39% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $299.0K | $300.0K | $510.0K |
| YoY Change | -41.37% | -41.18% | -12.82% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | $0.00 | $0.00 | $2.500M |
| YoY Change | -100.0% | -100.0% | -87.34% |
| Other Assets | $56.00K | $1.220M | $19.00K |
| YoY Change | 194.74% | -9.63% | -24.0% |
| Total Long-Term Assets | $1.523M | $1.520M | $4.354M |
| YoY Change | -65.02% | -65.06% | -80.41% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $15.05M | $15.05M | $52.22M |
| Total Long-Term Assets | $1.523M | $1.520M | $4.354M |
| Total Assets | $16.57M | $16.57M | $56.57M |
| YoY Change | -70.71% | -70.71% | -23.8% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $30.00K | $30.00K | $30.00K |
| YoY Change | 0.0% | -88.0% | -93.18% |
| Accrued Expenses | |||
| YoY Change | |||
| Deferred Revenue | $1.000M | ||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $0.00 | ||
| YoY Change | |||
| Total Short-Term Liabilities | $3.525M | $3.530M | $3.130M |
| YoY Change | 12.62% | 12.78% | -9.28% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $25.13M |
| YoY Change | -100.0% | -100.0% | 0.79% |
| Other Long-Term Liabilities | $3.000M | $5.040M | $3.000M |
| YoY Change | 0.0% | -17.65% | 0.0% |
| Total Long-Term Liabilities | $3.000M | $5.040M | $28.13M |
| YoY Change | -89.33% | -83.87% | 0.71% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $3.525M | $3.530M | $3.130M |
| Total Long-Term Liabilities | $3.000M | $5.040M | $28.13M |
| Total Liabilities | $8.563M | $8.560M | $34.38M |
| YoY Change | -75.09% | -75.1% | 1.06% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$167.3M | -$151.6M | |
| YoY Change | 10.36% | 14.88% | |
| Common Stock | $175.3M | $173.8M | |
| YoY Change | 0.86% | 0.87% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $8.007M | $8.010M | $22.20M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $16.57M | $16.57M | $56.57M |
| YoY Change | -70.71% | -70.71% | -23.8% |
Cashflow Statement
| Concept | 2017 Q4 | 2017 | 2016 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$2.960M | -$15.71M | -$5.710M |
| YoY Change | -48.16% | -19.96% | 47.93% |
| Depreciation, Depletion And Amortization | $60.00K | $279.0K | $70.00K |
| YoY Change | -14.29% | -7.0% | -12.5% |
| Cash From Operating Activities | -$2.690M | -$13.97M | -$4.280M |
| YoY Change | -37.15% | -18.14% | 8.35% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $0.00 | $79.00K | -$10.00K |
| YoY Change | -100.0% | -65.8% | -85.71% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $8.880M | $47.26M | -$4.190M |
| YoY Change | -311.93% | -1032.15% | -88.0% |
| Cash From Investing Activities | $8.880M | $47.18M | -$4.200M |
| YoY Change | -311.43% | -990.15% | -88.0% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 0.000 | -26.10M | 20.00K |
| YoY Change | -100.0% | -6625.25% | -133.33% |
| NET CHANGE | |||
| Cash From Operating Activities | -2.690M | -13.97M | -4.280M |
| Cash From Investing Activities | 8.880M | 47.18M | -4.200M |
| Cash From Financing Activities | 0.000 | -26.10M | 20.00K |
| Net Change In Cash | 6.190M | 7.112M | -8.460M |
| YoY Change | -173.17% | -132.39% | -78.31% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$2.690M | -$13.97M | -$4.280M |
| Capital Expenditures | $0.00 | $79.00K | -$10.00K |
| Free Cash Flow | -$2.690M | -$14.04M | -$4.270M |
| YoY Change | -37.0% | -18.78% | 10.05% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2016Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
2498000 | |
| CY2017Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
56000 | |
| CY2016Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
19000 | |
| CY2017Q4 | us-gaap |
Assets
Assets
|
16570000 | |
| CY2016Q4 | us-gaap |
Assets
Assets
|
56574000 | |
| CY2017Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2496000 | |
| CY2016Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2359000 | |
| CY2017Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
29000 | |
| CY2016Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
30000 | |
| CY2016Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
740000 | |
| CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3525000 | |
| CY2016Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
25127000 | |
| CY2016Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
3120000 | |
| CY2016Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-19000 | |
| CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
22198000 | |
| CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
56574000 | |
| CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | |
| CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2224384 | |
| CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2224384 | |
| CY2017 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
4026000 | |
| CY2016 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
3188000 | |
| CY2017 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
283000 | |
| CY2016 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
895000 | |
| CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7407000 | |
| CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8663000 | |
| CY2017 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
10651000 | |
| CY2016 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
12250000 | |
| CY2017 | us-gaap |
Operating Expenses
OperatingExpenses
|
18341000 | |
| CY2016 | us-gaap |
Operating Expenses
OperatingExpenses
|
21808000 | |
| CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14315000 | |
| CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-18620000 | |
| CY2017 | us-gaap |
Interest Expense
InterestExpense
|
747000 | |
| CY2016 | us-gaap |
Interest Expense
InterestExpense
|
1319000 | |
| CY2017 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
281000 | |
| CY2016 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
340000 | |
| CY2017 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-900000 | |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-15681000 | |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-19599000 | |
| CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
26000 | |
| CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
25000 | |
| CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15707000 | |
| CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19624000 | |
| CY2017 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-7.28 | |
| CY2017 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2156201 | |
| CY2017 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
18000 | |
| CY2016 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
96000 | |
| CY2016 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-19528000 | |
| CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
40225000 | |
| CY2016 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
270000 | |
| CY2016 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
172000 | |
| CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1059000 | |
| CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1474000 | |
| CY2017 | us-gaap |
Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
|
0 | |
| CY2017 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
279000 | |
| CY2016 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
304000 | |
| CY2017 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
1000 | |
| CY2016 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-4000 | |
| CY2017 | us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
89000 | |
| CY2016 | us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
-140000 | |
| CY2017 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
-2000 | |
| CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1474000 | |
| CY2017 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
98000 | |
| CY2016 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
198000 | |
| CY2017 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
882000 | |
| CY2017 | us-gaap |
Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
|
-179000 | |
| CY2017 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-183000 | |
| CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-324000 | |
| CY2017 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-11000 | |
| CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
79000 | |
| CY2017 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
19405000 | |
| CY2016 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
46000 | |
| CY2017 | us-gaap |
Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
|
1125000 | |
| CY2017 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
25000000 | |
| CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
396000 | |
| CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-21960000 | |
| CY2016 | us-gaap |
Interest Paid
InterestPaid
|
1033000 | |
| CY2017 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
2000 | |
| CY2016 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
29000 | |
| CY2017 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
2000 | |
| CY2017 | rkda |
Proceeds From Sale Of Fixed Assets Included In Prepaid Expenses And Other Current Assets
ProceedsFromSaleOfFixedAssetsIncludedInPrepaidExpensesAndOtherCurrentAssets
|
7000 | |
| CY2017 | us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
50000 | |
| CY2017 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;text-indent:5.24%;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions in the Company’s consolidated financial statements and notes thereto. Significant estimates and assumptions made by management included the determination of the provision for income taxes, costs to complete government grants and research contracts, net realizable value of inventory, and the development period of revenue-generating technologies. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p></div> | |
| CY2017 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <p style="margin-top:8pt;margin-bottom:0pt;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;text-indent:5.24%;">Concentration of Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Cash and cash equivalents are maintained with several financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with financial institutions with reputable credit and therefore bear minimal credit risk. The Company seeks to mitigate its credit risks by spreading such risks across multiple counterparties and monitoring the risk profiles of these counterparties.</p></div> | |
| CY2017 | us-gaap |
Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
|
<div> <p style="margin-top:18pt;margin-bottom:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Product Revenues</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Product revenues consist of sales of our SONOVA products. Product revenues are recognized once passage of title has occurred, contractually specified acceptance criteria have been met, and all other revenue recognition criteria have been met. Shipping and handling costs charged to customers are recorded as revenues and included in cost of product revenues at the time the sale is recognized.</p></div> | |
| CY2017 | us-gaap |
Revenue Recognition Services Licensing Fees
RevenueRecognitionServicesLicensingFees
|
<div> <p style="margin-top:18pt;margin-bottom:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">License Revenues</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">The Company’s license agreements generally include up-front, nonrefundable license fees, annual license fees, and subsequent milestone payments. Upon commercialization of a product utilizing a licensed technology, the Company receives certain value-sharing payments associated with the incremental revenue attributable to the licensed technology.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has determined that, at the inception of each license agreement, there is only one deliverable for the license for and access to the specified intellectual property. The up-front nonrefundable license fees are recognized as revenue proportionally over the development period. The development period is estimated based upon factors such as type of traits, nature of crops and geographies, which are used to establish the initial deferral period. The Company continually reviews such estimates based on progress toward product commercialization and performs a thorough analysis at least annually. If the deferral period estimate changes, the amount of revenue recognized during the period is either accelerated or reversed to reflect the updated deferred balances as of the current period-end, capturing the cumulative effect of the changes. The annual license fees are payable at the end of the annual period and such fees typically are not required to be paid if the agreement is cancelled prior to the due date. Therefore, annual license fees are only recognized when they become due. In the event a license is terminated prior to commercialization, the deferred balance of the unamortized up-front license is released to revenue on the effective date.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s license agreements generally include contingent milestone payments in the development life cycle of the related technology, such as achievement of specific technological targets, successful results from field trials, filing for approval with regulatory agencies, approvals granted by regulatory agencies and commercial launch of a product utilizing the licensed technology. The Company evaluates whether each milestone is substantive and at risk at the time the agreement is executed. This evaluation includes an assessment of whether (a) the consideration is commensurate with either (i) the entity’s performance to achieve the milestone or (ii) the enhancement of the value of the delivered item(s) as a result of a specific outcome resulting from the entity’s performance to achieve the milestone; (b) the consideration relates solely to past performance; and (c) the consideration is reasonable relative to all of the deliverables and payment terms within the arrangement. The Company generally considers non-refundable milestones that the Company expects to be achieved as a result of the Company’s efforts during the period of the Company’s performance obligations under the license agreement to be substantive and recognizes them as revenue upon the achievement of the milestone, assuming all other revenue recognition criteria are met.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Once a product containing one or more of the Company’s traits is commercialized, the Company is entitled to receive a portion of the incremental revenue that the trait generates for its commercial partner. These value-sharing payments will be recorded on the accrual basis when results are reliably measurable, collectability is reasonably assured, and all other revenue recognition criteria are met. None have been received to date.</p></div> | |
| CY2017 | us-gaap |
Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
|
<div> <p style="margin-top:18pt;margin-bottom:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Unearned Revenue</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">The Company defers revenue to the extent that cash received in conjunction with a license agreement, contract or grant exceeds the revenue recognized in accordance with Company policies.</p></div> | |
| CY2016Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
98000 | |
| CY2017Q4 | rkda |
Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
|
32000 | |
| CY2016Q4 | rkda |
Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
|
29000 | |
| CY2017Q4 | rkda |
Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
|
51000 | |
| CY2016Q4 | rkda |
Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
|
85000 | |
| CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
83000 | |
| CY2017 | us-gaap |
Variable Interest Entity Terms Of Arrangements
VariableInterestEntityTermsOfArrangements
|
Both the Company and Bioceres incur expenses in support of specific activities agreed, as defined by joint work plans, which apply fair market value to each partner’s activities. Unequal contributions of services are equalized by the partners through cash payments. Verdeca is not the primary obligor for these activities performed by the Company or Bioceres. An agreement executed in conjunction with the formation of Verdeca specified that if Bioceres determines it requires cash to fund its contributed services (subject to certain annual limits), Bioceres, S.A. may elect to sell shares of its common stock to the Company for an amount not exceeding $5.0 million in the aggregate over a four-year period. | |
| CY2017 | rkda |
Contributed Services Period
ContributedServicesPeriod
|
P4Y | |
| us-gaap |
Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
|
2000000 | ||
| CY2014Q3 | rkda |
Common Stock Shares Surrendered
CommonStockSharesSurrendered
|
1832 | |
| CY2015 | rkda |
Research Agreement Settled
ResearchAgreementSettled
|
205000 | |
| CY2015Q4 | us-gaap |
Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
|
632 | |
| CY2015Q4 | us-gaap |
Fair Value Hedges At Fair Value Net
FairValueHedgesAtFairValueNet
|
500000 | |
| CY2015Q4 | us-gaap |
Cost Method Investments
CostMethodInvestments
|
0 | |
| CY2017 | us-gaap |
Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
|
912000 | |
| CY2017Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
366000 | |
| CY2016Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
222000 | |
| CY2017Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
805000 | |
| CY2016Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1331000 | |
| CY2017Q4 | rkda |
Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
|
899000 | |
| CY2016Q4 | rkda |
Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
|
182000 | |
| CY2017Q4 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
177000 | |
| CY2016Q4 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
170000 | |
| CY2017Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
0 | |
| CY2017 | dei |
Entity Incorporation State Country Name
EntityIncorporationStateCountryName
|
Arizona | |
| CY2017 | rkda |
Entity Incorporation Year Of Incorporation
EntityIncorporationYearOfIncorporation
|
2002 | |
| CY2017 | rkda |
Entity Reincorporation State Country Name
EntityReincorporationStateCountryName
|
Delaware | |
| CY2017 | rkda |
Entity Reincorporation Date Of Reincorporation
EntityReincorporationDateOfReincorporation
|
2015-03 | |
| CY2017 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1:20 | |
| CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
0 | |
| CY2016Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
0 | |
| CY2017 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | |
| CY2016 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
500000 | |
| CY2017Q4 | rkda |
Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
|
45000 | |
| CY2016Q4 | rkda |
Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
|
44000 | |
| CY2017Q4 | rkda |
Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
|
1352000 | |
| CY2016Q4 | rkda |
Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
|
1535000 | |
| CY2017Q4 | rkda |
Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
|
1397000 | |
| CY2016Q4 | rkda |
Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
|
1579000 | |
| CY2017 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
| CY2016 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
| CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
5180000 | |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
5449000 | |
| CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4881000 | |
| CY2016Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4941000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
12842000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
1000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
12841000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
52613000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
0 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
19000 | |
| CY2016Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
52594000 | |
| CY2017Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
0 | |
| CY2017Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
12841000 | |
| CY2016Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
52594000 | |
| CY2016Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
45000 | |
| CY2017Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
24000 | |
| CY2016Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
0 | |
| CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
59000 | |
| CY2016Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
197000 | |
| CY2016 | us-gaap |
Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
|
23 | |
| CY2016 | us-gaap |
Other Restructuring Costs
OtherRestructuringCosts
|
0 | |
| CY2017 | us-gaap |
Other Restructuring Costs
OtherRestructuringCosts
|
0 | |
| CY2017Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
0 | |
| CY2016Q4 | us-gaap |
Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
|
25127000 | |
| CY2016Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
25127000 | |
| CY2016Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
0 | |
| CY2017 | rkda |
Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
|
2 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
171375 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
89970 | |
| CY2016 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
11407 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
20999 | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
228939 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
111336 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
52146 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
288129 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
282394 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
144743 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
75.20 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
103.50 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
23.63 | |
| CY2017 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | |
| CY2016 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | |
| CY2017 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
2000 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
89.84 | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
87.60 | |
| CY2016 | rkda |
Milestones Payment
MilestonesPayment
|
0 | |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-15681000 | |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-19599000 | |
| CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
0 | |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
0 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.00 | |
| CY2017 | rkda |
Effective Income Tax Rate Reconciliation Withholding Taxes
EffectiveIncomeTaxRateReconciliationWithholdingTaxes
|
-0.002 | |
| CY2016 | rkda |
Effective Income Tax Rate Reconciliation Withholding Taxes
EffectiveIncomeTaxRateReconciliationWithholdingTaxes
|
-0.001 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
|
-0.035 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
13.47 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
61.60 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
63.62 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
63.95 | |
| CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
79.53 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
3707000 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | |
| CY2017 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | |
| CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
449000 | |
| CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
283000 | |
| CY2017Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
1100000 | |
| CY2017 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y8M26D | |
| CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
9.20 | |
| CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
22.60 | |
| CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
422000 | |
| CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
77000 | |
| CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
72000 | |
| CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
571000 | |
| CY2017 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1200000 | |
| CY2016 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1300000 | |
| CY2017Q4 | rkda |
Royalties On Licensed Revenue Accrued
RoyaltiesOnLicensedRevenueAccrued
|
206000 | |
| CY2016Q4 | rkda |
Royalties On Licensed Revenue Accrued
RoyaltiesOnLicensedRevenueAccrued
|
201000 | |
| CY2017 | rkda |
Milestones Payments Yet To Be Achieved
MilestonesPaymentsYetToBeAchieved
|
2000000 | |
| CY2016 | rkda |
Milestones Payments Yet To Be Achieved
MilestonesPaymentsYetToBeAchieved
|
2000000 | |
| CY2017 | rkda |
Milestones Payment
MilestonesPayment
|
0 | |
| CY2016 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
1000 | |
| CY2017 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
24000 | |
| CY2016 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
24000 | |
| CY2017 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
26000 | |
| CY2016 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
25000 | |
| CY2017 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | |
| CY2016 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | |
| CY2017 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
0 | |
| CY2016 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
0 | |
| CY2017 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
0 | |
| CY2016 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
0 | |
| CY2017 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | |
| CY2016 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.340 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.340 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.026 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.047 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.914 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.378 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.001 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.009 | |
| CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-1.246 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
|
0.00 | |
| CY2016 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.001 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
37498000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
49593000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
783000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
1501000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2273000 | |
| CY2017 | us-gaap |
Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
|
0.03 | |
| CY2017 | us-gaap |
Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
|
Employees’ rights to employer contributions vest on the one-year anniversary of their date of employment. | |
| CY2017 | rkda |
Defined Benefit Plan Contribution Vesting Period
DefinedBenefitPlanContributionVestingPeriod
|
P1Y | |
| CY2017 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
0 | |
| CY2016 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
0 | |
| CY2017 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
354974 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2861000 | |
| CY2017Q4 | rkda |
Deferred Tax Assets Accrued Payroll And Benefits
DeferredTaxAssetsAccruedPayrollAndBenefits
|
51000 | |
| CY2016Q4 | rkda |
Deferred Tax Assets Accrued Payroll And Benefits
DeferredTaxAssetsAccruedPayrollAndBenefits
|
215000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
171000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
143000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
|
0 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
|
13000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
128000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
191000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
396000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
1110000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
3000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
5000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
41303000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
55632000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
41303000 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
55632000 | |
| CY2017Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | |
| CY2017 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-14300000 | |
| CY2016 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
8500000 | |
| CY2017 | us-gaap |
Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
|
it has not forfeited the right to carryforward tax losses up to 20 years | |
| CY2017 | rkda |
Income Tax Examination Year Open Back Under Examination
IncomeTaxExaminationYearOpenBackUnderExamination
|
2000 | |
| CY2017Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2017 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
|
0.50 | |
| CY2016 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
295784 | |
| CY2017Q1 | rkda |
Minimum Bid Price Common Stock Failed To Maintain
MinimumBidPriceCommonStockFailedToMaintain
|
1.00 | |
| CY2017Q1 | rkda |
Duration Of Consecutive Business Days Common Stock Failed To Maintain Minimum Bid Price Or Greater
DurationOfConsecutiveBusinessDaysCommonStockFailedToMaintainMinimumBidPriceOrGreater
|
P30D |
